Haisco Pharmaceutical Group Co Ltd
002653
Company Profile
Business description
Haisco Pharmaceutical Group Co Ltd is a pharmaceutical company based in China. It is mainly engaged in the research, development, manufacture, and sale of drugs for liver disease. Its product portfolio includes parenteral nutrition drugs, antibiotics, anesthetic agents, digestive system drugs and tumour adjuvant drug series. The company's products are being used in first rank hospitals in China.
Contact
No. 17, Sanxiang Avenue
Shannan District
Tibet Autonomous Region
Zetang856000
CHNT: +86 8937834865
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
5,337
Stocks News & Analysis
stocks
Stellar growth from ASX retailer but markets still too optimistic
This Australian success story looks set to face profit margin compression from the scariest of competitors.
stocks
How to focus on the right things this reporting season
For individual investors, it is important to frame earnings season revelations in a long-term way.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,141.70 | 24.10 | 0.26% |
| CAC 40 | 7,698.52 | 44.48 | -0.57% |
| DAX 40 | 24,081.34 | 81.52 | -0.34% |
| Dow JONES (US) | 43,975.09 | 200.52 | -0.45% |
| FTSE 100 | 9,129.71 | 33.98 | 0.37% |
| HKSE | 24,929.34 | 22.53 | 0.09% |
| NASDAQ | 21,385.40 | 64.62 | -0.30% |
| Nikkei 225 | 42,969.07 | 1,148.59 | 2.75% |
| NZX 50 Index | 12,804.18 | 107.68 | -0.83% |
| S&P 500 | 6,373.45 | 16.00 | -0.25% |
| S&P/ASX 200 | 8,873.60 | 28.80 | 0.33% |
| SSE Composite Index | 3,666.33 | 18.78 | 0.51% |